150 related articles for article (PubMed ID: 35892851)
1. Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort.
Schölzchen J; Treese C; Thuss-Patience P; Mrózek A; Rau B; Seeliger H; Hartmann D; Estevéz-Schwarz L; Siegmund B; Horn D; Nassir M; Daum S
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892851
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.
Garcia-Pelaez J; Barbosa-Matos R; São José C; Sousa S; Gullo I; Hoogerbrugge N; Carneiro F; Oliveira C
Eur J Med Genet; 2022 Jan; 65(1):104401. PubMed ID: 34871783
[TBL] [Abstract][Full Text] [Related]
3. Hereditary gastric cancer: what's new? Update 2013-2018.
van der Post RS; Oliveira C; Guilford P; Carneiro F
Fam Cancer; 2019 Jul; 18(3):363-367. PubMed ID: 30989426
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
5. Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution.
Zhao E; Ling T; Xu J; Zhao G; Cao H; Giacopuzzi S; Bencivenga M; de Manzoni G
Int J Clin Exp Med; 2015; 8(7):10668-77. PubMed ID: 26379858
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.
Treese C; Siegmund B; Daum S
Curr Oncol; 2022 Mar; 29(4):2454-2460. PubMed ID: 35448173
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
9. Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.
Carvalho J; Oliveira P; Senz J; São José C; Hansford S; Teles SP; Ferreira M; Corso G; Pinheiro H; Lemos D; Pascale V; Roviello F; Huntsman D; Oliveira C
J Med Genet; 2021 Jan; 58(1):1-11. PubMed ID: 32066632
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
Llach J; Salces I; Guerra A; Peñas B; Rodriguez-Alcalde D; Redondo PD; Cubiella J; Murcia Ó; Escalante M; Gratacós-Ginès J; Pocurull A; Daca-Alvarez M; Luzko I; Sánchez A; Herrera-Pariente C; Ocaña T; Carballal S; Elizalde I; Castellví-Bel S; Fernández-Esparrach G; Castells A; Balaguer F; Moreira L
Int J Cancer; 2024 Jan; 154(1):124-132. PubMed ID: 37676082
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer.
Donner I; Kiviluoto T; Ristimäki A; Aaltonen LA; Vahteristo P
Fam Cancer; 2015 Jun; 14(2):241-6. PubMed ID: 25576241
[TBL] [Abstract][Full Text] [Related]
14. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the pathology of heritable gastric cancer syndromes.
Gullo I; van der Post RS; Carneiro F
Histopathology; 2021 Jan; 78(1):125-147. PubMed ID: 33382491
[TBL] [Abstract][Full Text] [Related]
16.
Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
20. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
